Medical Xpress

Using exome sequencing to analyze copy number variants can increase diagnostic yield

Chromosomal microarray (CMA) is traditionally used to detect CNVs, but it may not always be clinically ordered. Additionally, it is limited to detecting larger CNVs (typically larger than 50kb), which ...
Business Wire

Variantyx Expands Its Reproductive Health Offerings with Launch of a Direct Replacement for Chromosomal Microarray Analysis

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine, today announced the launch of its IriSight™ CNV Analysis - a whole genome-based test for the detection of ...
FierceBiotech

CombiMatrix Corporation Selects Cartagenia BENCHlab CNV Platform to Bolster Expanded Lab Operations

BOSTON, Nov. 1, 2012 /PRNewswire/ -- Cartagenia, the world leader in providing genetic labs and clinicians software-based workflow support for variant assessment, lab reporting, and integration of ...
Business Wire

New Data from Universal DX: Combining Copy Number Variation (CNV) with cfDNA Fragment Size Information Could Serve as Promising New Avenue for Early Detection of Colorectal ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Universal Diagnostics (Universal DX), a bioinformatics and multi-omics company on a mission to transform cancer into a curable disease, today announced the results ...
Labroots

HRD Evaluation and Scoring using OncoScan CNV Assay, a whole-genome microarray research solution

Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhibitors, ...